Biovitrum to Present at the 27th Annual J.P. Morgan Healthcare Conference
* Reuters is not responsible for the content in this press release.
STOCKHOLM, SWEDEN, Jan 12 (MARKET WIRE) --
Biovitrum's CEO Martin Nicklasson will give a company presentation at the
27th Annual J.P. Morgan Healthcare Conference being held January 12-15,
2009, in San Francisco, USA.
The presentation is scheduled to take place on Wednesday January 14 at
4:00 p.m. (PST). A live webcast, as well as an archived, will be
available via Biovitrums website at www.biovitrum.com. The presentation
material will be available on www.biovitrum.com under the link
presentations on the investor relations page.
About Biovitrum
Biovitrum is a pharmaceutical company with operations in Sweden and in
the UK. The company markets a range of specialist pharmaceuticals. Using
its expertise and experience Biovitrum takes scientific innovation all
the way to the market and to specialist indication patients with
significant medical need. Research expertise and capabilities include
development and production of biotechnology therapeutics, as well as
small molecule discovery and development. With revenues of approximately
SEK 1.3 billion and around 500 employees, Biovitrum is a significant
international specialty pharmaceutical player. Biovitrum's share is
listed on the OMX Nordic Exchange in Stockholm. For more information go to
www.biovitrum.com
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
Copyright Copyright Hugin AS 2009. All rights reserved.
For more information please contact:
Biovitrum
Goeran Arvidson
CFO
Phone: +46 8 697 23 68
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters